Tractebel and IBA, the world leader in particle accelerator technology, join forces to support the construction of proton therapy facilities that contribute to treating cancer around the world.
Tractebel and IBA have signed a partnership agreement to strengthen their cooperation in the field of proton therapy, an advanced form of radiation therapy designed to kill cancer cells. The agreement provides that IBA will promote Tractebel’s engineering services to its prospective customers to help them design and build proton therapy facilities.
Tractebel has unique experience in providing engineering services, consultancy and training for complex healthcare projects. This will enable us to complement IBA’s offering of world-class proton therapy technology solutions by supporting healthcare players in the construction process of the buildings that host the technology.
To provide customers with more information on proton therapy construction projects and on our expertise in this field, IBA and Tractebel will jointly carry out marketing activities and prepare extended services offerings.
A successful collaboration
The two companies have already collaborated on several projects, such as structural integrity reviews in the event of an earthquake, cost estimation tools for IBA’s Proteus facilities, stability studies related to the installation of a compact proton therapy unit into an existing one, and engineering support for the design of proton therapy facilities including BIM modelling.
Luk Herremans (Executive Vice President Commercial Operations Proton Therapy, IBA), Bernard Dereeper (Head of Business Development & Strategy – Business Line Nuclear, Tractebel) and Denis Dumont (General Manager Business Line Nuclear, Tractebel).
“We have worked for several years with Tractebel on a variety of projects. It has enabled Tractebel to gain an extensive knowledge of the building requirements of our proton therapy systems, making them the perfect design and engineering partner. Listening to the market, there is an obvious need for a company that can guide our customers through the design and building journey and help them to make it as efficient and smooth as possible. We look forward to collaborating with Tractebel to offer an even more complete service to the market.”
Luk Herremans, Executive Vice President Commercial Operations Proton Therapy, IBA
“We are honored to join forces once again with IBA, a global leader in proton therapy and medical equipment. Combining our expertise in designing medical installations, our nuclear- and radiation-related competences and our multidisciplinary approach with IBA’s world-class radiation therapy technology will enable us to offer high-level and fully integrated services from facilities design and engineering to the system itself. We are proud that our engineers’ know-how will contribute to improving cancer treatment around the world.”
Bernard Dereeper, Head of Business Development & Strategy – Business Line Nuclear, Tractebel
More information can be found at: www.iba-worldwide.com
Discover more about our Nuclear4Medical solutions and Our urban healthcare references
On December 4, the Royal Family of Monaco officially inaugurated Mareterra, an exceptional district that expands Monaco's territory by three percent. As Owner’s...
Find out more
At Tractebel, around 1/3 of our employees are women. And we're aiming to have 40% women in management by 2030. In this episode of the « Engineering Angles” podcast, Daphné...
Find out more
Tractebel will assist Steady Energy, a pioneer in Small Modular Reactor (SMR) technology development, in its LDR-50 nuclear reactor design and licensing process....
Find out more
Tractebel contributes to upgrading the French nuclear fleet, which provides over 70% of France’s low-carbon electricity, to extend its lifetime beyond 40 years. Jointly with...
Find out more